A case of Rothia dentocariosa bacteremia in a patient receiving infliximab for ulcerative colitis

Am J Gastroenterol. 2014 Feb;109(2):297-8. doi: 10.1038/ajg.2013.366.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Actinomycetales / classification*
  • Actinomycetales Infections / diagnosis*
  • Actinomycetales Infections / drug therapy
  • Actinomycetales Infections / immunology
  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / immunology
  • Bacteremia / microbiology*
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / immunology
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Male
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / immunology
  • Opportunistic Infections / microbiology*
  • Risk Assessment
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Infliximab